BBLG READ THE FULL BBLG RESEARCH REPORT Bone Biologics (NASDAQ:BBLG) announced the company’s 3Q 2024 financial results and while a company at this stage is far more reliant on testing of products, ...

Lower back surgery represents a life-changing decision that demands careful consideration. While many view surgery as a ...

H.C. Wainwright analyst Matthew Caufield reiterated a Buy rating on FibroBiologics, Inc. (FBLG – Research Report) today and set a price ...

Among the patients who visit the hospital due to back pain, the most diagnosed disease is 'intervertebral disc ...

An estimated 23 percent of adults worldwide suffer from chronic low back pain, and as many as 84 percent of us will ...

Theradaptive, a privately held, clinical stage biologics company developing targeted protein therapeutics for spine, orthopedics, soft tissue repair and targeted immuno-oncology, today announced the ...

The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance to a standalone lateral lumbar interbody fusion device from the internationally renowned surgeon Randal Betz, M.D.’s company, ...

New blinded preliminary safety and efficacy data from the ongoing Phase 2 clinical trial of BRTX-100 to be described in podium presentation on ...

Healing Edge recognizes that the path to wellness is unique for each individual.

New treatments for Alzheimer disease don’t reverse cognitive symptoms, but they do significantly slow progression. Evidence suggests that earlier treatment is most effective. In his first ...

Constipation in Crohn’s disease may be caused by lifestyle and dietary factors, as well as medical conditions like strictures. Treatment may include eating more fiber, taking laxatives ...